M-1/M-2 macrophages and the Th1/Th2 paradigm

Journal of Immunology

Volumn 164, Issue 12, 2000, Pages 6166-6173

  Mills, Charles D ^a,b   Kincaid, Kristi ^a   Alt, Jennifer M ^a   Heilman, Michelle J ^a   Hill, Annette M ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CYTOKINE PRODUCTION; FEMALE; INFLAMMATION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

EID: 0034659784     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.12.6166     Document Type: Article

References (64)

1. Metchnikoff, E. 1905. Immunity in Infective Diseases. Cambridge University Press, New York.
2. Mackaness, G. B. 1964. The immunological basis of acquired cellular resistance J. Exp. Med. 120:105.
3. North, R. J. 1978. The concept of the activated macrophage. J. Immunol. 121: 806.
4. Adams, D. O., and T. A. Hamilton. 1984. The cell biology of macrophage activation. Annu. Rev. Immunol. 2:283.
5. Hibbs, J. B. Jr., Z. Vavrin, and R. R. Taintor. 1987. L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J. Immunol. 138:550.
6. Nathan, C. F. 1987. Secretory products of macrophages. J. Clin. Invest. 79:319.
7. Nathan, C. F., and J. B. Hibbs Jr. 1991. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3:65.
8. Podolsky, S. H., and A. I. Tauber. 1996. Darwinism and antibody diversity: a historical perspective. Res. Immunol. 147:199.
9. Hoffmann, J. A., F. C. Kafatos, C. A. Janeway, and R. A. Ezekowitz. 1999. Phylogenetic perspectives in innate immunity. Science 284:1313.
10. Mosmann, T. R., and R. L. Coffman. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145.
11. Gazzinelli, R. T., S. Hieny, T. A. Wynn, S. Wolf, and A. Sher. 1993. Interleukin 12 is required for the T-lymphocyte-independent induction of interferon γ by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc. Natl. Acad. Sci. USA 90:6115.
12. O'Garra, A., and K. Murphy. 1994. Role of cytokines in determining T-lymphocyte function. Curr. Opin. Immunol. 6:458.
13. Scott, P., P. Natovitz, R. L. Coffman, E. Pearce, and A. Sher. 1988. Immuno-regulation of cutaneous leishmaniasis: T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J. Exp. Med. 168:1675.
14. Heinzel, F. P., M. D. Sadick, B. J. Holaday, R. L. Coffman, and R. M. Locksley. 1989. Reciprocal expression of interferon γ or interleukin 4 during the resolution or progression of murine leishmaniasis: evidence for expansion of distinct helper T cell subsets. J. Exp. Med. 169:59.
15. Munder, M., K. Eichmann, J. M. Moran, F. Centeno, G. Soler, and M. Modolell. 1999. Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells. J. Immunol. 163:3771.
16. Hsieh, C. S., S. E. Macatonia, A. O'Garra, and K. M. Murphy. 1995. T cell genetic background determines default T helper phenotype development in vitro. J. Exp. Med. 181:713.
17. Buchmuller-Rouiller, Y., and J. Mauel. 1986. Correlation between enhanced oxidative metabolism and leishmanicidal activity in activated macrophages from healer and nonhealer mouse strains. J. Immunol. 136:3884.
18. Liew, F. Y., Y. Li, D. Moss, C. Parkinson, M. V. Rogers, and S. Moncada. 1991. Resistance to Leishmania major infection correlates with the induction of nitric oxide synthase in murine macrophages. Eur. J. Immunol. 21:3009.
19. Oswald, I. P., S. Afroun, D. Bray, J. F. Petit, and G. Lemaire. 1992. Low response of BALB/c macrophages to priming and activating signals. J. Leukocyte Biol. 52:315.
20. Stenger, S., H. Thuring, M. Rollinghoff, and C. Bogdan. 1994. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J. Exp. Med. 180:783.
21. Dileepan, K. N., J. C. Page, and D. J. Stechschulte. 1995. Direct activation of murine peritoneal macrophages for nitric oxide production and tumor cell killing by interferon γ. J. Interferon Cytokine Res. 15:387.
22. Chakkalath, H. R., and R. G. Titus. 1994. Leishmania major-parasitized macrophages augment Th2-type T cell activation. J. Immunol. 153:4378.
23. Pulendran, B., J. L. Smith, G. Caspary, K. Brasel, D. Pettit, E. Maraskovsky, and C. R. Maliszewski. 1999. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc. Natl. Acad. Sci. USA 96:1036.
24. + subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J. Exp. Med. 189:587.
25. Rissoan, M. C., V. Soumelis, N. Kadowaki, G. Grouard, F. Briere, R. de Waal Malefyt, and Y. J. Liu. 1999. Reciprocal control of T helper cell and dendritic cell differentiation. Science 283:1183.
26. Kalinski, P., C. M. Hilkens, E. A. Wierenga, and M. L. Kapsenberg. 1999. T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol. Today 20:561.
27. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245.
28. Williams-Ashman, H. G., and Z. N. Canellakis. 1979. Polyamines in mammalian biology and medicine. Perspect. Biol. Med. 22:421.
29. Wu, G., and S. M. Morris Jr. 1998. Arginine metabolism: nitric oxide and beyond. Biochem. J. 336:1.
30. Mills, C. D. 1991. Molecular basis of "suppressor" macrophages: arginine metabolism via the nitric oxide synthetase pathway. J. Immunol. 146:2719.
31. Mills, C. D., J. D. Shearer, and M. D. Caldwell. 1992. Macrophage arginine metabolism via nitric oxide synthase or arginase equates with immunosurveillance or immunostimulation of cancer. In The Biology of Nitric Oxide. S. Moncada, ed. Portland Press, Chapel Hill, p. 228.
32. Ding, A. H., C. F. Nathan, and D. J. Stuehr. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J. Immunol. 141:2407.
33. Rosenthal, A. S., and E. M. Shevach. 1973. Function of macrophages in antigen recognition by guinea pig T lymphocytes. I. Requirement for histocompatible macrophages and lymphocytes. J. Exp. Med. 138:1194.
34. Unanue, E. R. 1984. Antigen-presenting function of the macrophage. Annu. Rev. Immunol. 2:395.
35. Leibovich, S. J., and R. Ross. 1975. The role of the macrophage in wound repair: a study with hydrocortisone and antimacrophage serum. Am. J. Pathol. 78:71.
36. Folkman, J., and M. Klagsbrun. 1987. Angiogenic factors. Science 235:442.
37. Albina, J. E., C. D. Mills, W. L. Henry Jr., and M. D. Caldwell. 1990. Temporal expression of different pathways of L-arginine metabolism in healing wounds. J. Immunol. 144:3877.
38. Banan, A., S. A, McCormack, and L. R. Johnson. 1998. Polyamines are required for microtubule formation during gastric mucosal healing. Am. J. Physiol. 274: G879.
39. Chung, D. H., B. M. Evers, C. M. Townsend Jr., K. F. Huang, D. N. Herndon, and J. C. Thompson. 1993. Role of polyamine biosynthesis during gut mucosal adaptation after burn injury. Am. J. Surg. 165:144.
40. Albina, J. E., J. A. Abate, and B. Mastrofrancesco. 1993. Role of ornithine as a proline precursor in healing wounds. J. Surg. Res. 55:97.
41. Mills, C. D., J. Shearer, R. Evans, and M. D. Caldwell. 1992. Macrophage arginine metabolism and the inhibition or stimulation of cancer. J. Immunol. 149: 2709.
42. Pace, J. L., and S. W. Russell. 1981. Activation of mouse macrophages for tumor cell killing. I. Quantitative analysis of interactions between lymphokine and lipopolysaccharide. J. Immunol. 126:1863.
43. Weinberg, J. B., H. A. Chapman Jr., and J. B. Hibbs Jr. 1978. Characterization of the effects of endotoxin on macrophage tumor cell killing. J. Immunol. 121:72.
44. Diefenbach, A., H. Schindler, N. Donhauser, E. Lorenz, T. Laskay, J. MacMicking, M. Rollinghoff, I. Gresser, and C. Bogdan. 1998. Type 1 interferon (IFNα/β) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity 8:77.
45. Ding, A., C. F. Nathan, J. Graycar, R. Derynck, D. J. Stuehr, and S. Srimal. 1990. Macrophage deactivating factor and transforming growth factors-β1, -β2, and -β3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-γ. J. Immunol. 145:940.
46. Vodovotz, Y., C. Bogdan, J. Paik, Q. W. Xie, and C. Nathan. 1993. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor β. J. Exp. Med. 178:605.
47. Boutard, V., R. Havouis, B. Fouqueray, C. Philippe, J. P. Moulinoux, and L. Baud. 1995. Transforming growth factor-β stimulates arginase activity in macrophages: implications for the regulation of macrophage cytotoxicity. J. Immunol. 155:2077.
48. Scharton-Kersten, T., L. C. Afonso, M. Wysocka, G. Trinchieri, and P. Scott. 1995. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J. Immunol. 154:5320.
49. Wilson, M. E., B. M. Young, B. L. Davidson, K. A. Mente, and S. E. McGowan. 1998. The importance of TGF-β in murine visceral leishmaniasis. J. Immunol. 161:6148.
50. Li, J., C. A. Hunter, and J. P. Fanell. 1999. Anti-TGF-β treatment promotes rapid healing of Leishmania major infection in mice by enhancing in vivo nitric oxide production. J. Immunol. 162:974.
51. Nunes, I., R. L. Shapiro, and D. B. Rifkin. 1995. Characterization of latent TGF-β activation by murine peritoneal macrophages. J. Immunol. 155:1450.
52. Tsunawaki, S., M. Sporn, A. Ding, and C. Nathan. 1988. Deactivation of macrophages by transforming growth factor-β. Nature 334:260.
53. + hemopoietic progenitors. J. Immunol. 157:1499.
54. Albina, J. E., M. D. Caldwell, W. L. Henry Jr., and C. D. Mills. 1989. Regulation of macrophage functions by L-arginine. J. Exp. Med. 169:1021.
55. Carrel, A., and A. H. Ebeling. 1926. The transformation of monocytes into fibroblasts through the action of Rous virus. J. Exp. Med. 43:461.
56. Godoy, M., M. Geuskens, E. A. Van Marck, R. Borojevic, and P. Van Gansen. 1989. Schistosomiasis and in vitro transdifferentiation of murine peritoneal macrophages into fibroblastic cells. Parasitol. Res. 76:150.
57. Shearer, J. D., J. R. Richards, C. D. Mills, and M. D. Caldwell. 1997. Differential regulation of macrophage arginine metabolism: a proposed role in wound healing. Am. J. Physiol. 272:E181.
58. 1 lupus-prone mice and the Leishmania major-susceptible BALB/c strain. J. Immunol. 161:6878.
59. Matzinger, P. 1994. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12:991.
60. Bluestone, J. A. 1998. Cell fate in the immune system: decisions, decisions, decisions. Immunol. Rev. 165:5.
61. Eisenstein, T. K. 1994. Suppressor macrophages. Immunol. Ser. 60:203.
62. Koblish, H. K., C. A. Hunter, M. Wysocka, G. Trinchieri, and W. M. Lee. 1998. Immune suppression by recombinant interleukin (rIL)-12 involves interferon γ induction of nitric oxide synthase 2 (iNOS) activity: inhibitors of NO generation reveal the extent of rIL-12 vaccine adjuvant effect. J. Exp. Med. 188:1603.
63. Tarrant, T. K., P. B. Silver, J. L. Wahlsten, L. V. Rizzo, C. C. Chan, B. Wiggert, and R. R. Caspi. 1999. Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving Interferon γ, nitric oxide, and apoptosis. J. Exp. Med. 189:219.
64. Modolell, M., I. M. Corraliza, F. Link, G. Soler, and K. Eichmann. 1995. Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines. Eur. J. Immunol. 25:1101.